Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-22-021376

Options or other derivatives

  • Chief Development Officer acquired 311,437 shares (grant or award)
  • Chief Development Officer returned 311,437 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

LeBel Carl · Chief Development Officer

Table II: Derivative

6 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-08-17 Grant or award : show line 1 in the form Stock Option +178,937 $2.14 2029-10-01 178,937 178,937 D
2022-08-17 Returned to the company : show line 2 in the form Stock Option −178,937 $14.00 2029-10-01 178,937 0 D
2022-08-17 Grant or award : show line 3 in the form Stock Option +75,000 $2.14 2031-01-14 75,000 75,000 D
2022-08-17 Returned to the company : show line 4 in the form Stock Option −75,000 $35.85 2031-01-14 75,000 0 D
2022-08-17 Grant or award : show line 5 in the form Stock Option +57,500 $2.14 2030-02-11 57,500 57,500 D
2022-08-17 Returned to the company : show line 6 in the form Stock Option −57,500 $25.05 2030-02-11 57,500 0 D
Loading xslF345X03/form4.xml…